03/29/2017 2:50 am EST


Todd Shaver

Founder and Editor-in-Chief, BullMarket.com

Israel-based Mazor Robotics (MZOR) has teamed up with Dublin, Ireland-based Medtronic (MDT) to co-market and promote the Mazor X. 

Mazor X expands on the company’s robotic guidance technology to include analytical tools, multiple-source data, precision guidance, optical tracking, intra-op verification and connectivity technologies. That is a lot of jargon, but we tell you this so that you know that Mazor X is a key technology for spine surgery.

Mazor is at a key inflection point, in our view, having generated record sales in the most recent quarter. Specifically, the 21 systems ordered during the most recent quarter illustrated strong ongoing demand – strong news on the fundamentals.

What is more exciting is that there is a clear and significant shift toward direct orders for the Mazor X system. Importantly, of the 21 systems currently in backlog, 18 are for Mazor X and only six of those are from Medtronic. 

This indicates significant bottom-up demand from surgeons. The Medtronic partnership is a good starting point, but the business is picking up momentum on its own. What is harder to do than spine surgery? Mazor is a top player in the space that is delivering on growth. We see compelling value in the stock.

Subscribe to Todd Shaver's Bullmarket.com here…

  By clicking submit, you agree to our privacy policy & terms of service.

Related Articles on HEALTHCARE

Keyword Image
All That JAZZ
12/11/2018 5:00 am EST

Jazz Pharmaceuticals (JAZZ). is the type of stock that should protect you in case of a bear market w...

Keyword Image
Invitae: The Second Time Around
12/06/2018 5:00 am EST

In 2017, Invitae Corporation (NVTA) was growing at a rapid clip. But it was burning through cash at ...